JPRN-UMIN000014273CompletedPhase 2
Open study to compare twelve week continuous ingestion effect of Champignon extract on fecal odor, body odor, oral odor and enteric environment of the subjects. - Effects of Champignon extract on fecal odor, body odor, oral odor and enteric environment of the subjects.
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Enrollment
- 16
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 50years-old to 80years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1. Subjects who are suffering from chronic diseases (such as cancer, liver disease, kidney disease, heart disease, gastrointestinal disorders, diabetes, dyslipidemia, hypertension, mental illness) or currently under its treatment. 2. Subjects who are suffering from serious cerebrovascular disease, heart disease, liver disease, renal disease, gastrointestinal disease or any infectious disease which needs immediate reporting. 3. Subjects having a clinical history of gastrectomy, gastrointestinal suture, bowel resection or any major surgery in the digestive system. 4. Subjects who will undergo dental treatment during this study period. 5. Subjects with frequent complaints of post-menopausal symptoms. 6. Subjects with unusually high and/or low blood pressure, or with abnormal hematological data. 7. Subjects with serious anemia. 8. Subjects with a history of allergy to medicine and food (especially mushroom). 9. Subjects who have defecation frequency less than four times per week or those who suffer from diarrhea 10. Subjects under the medication for bowel movements (such as antibiotics, laxatives, medicine for constipation) or using functional foods and supplements (containing lactic acid bacteria, bifidobacterium, oligosaccharides, dietary fiber etc.) 11. Subjects who are heavy smokers or alcoholics, or exhibit irregular pattern in their lifestyles such as meals or sleep etc. 12. Subject who has donated 400ml whole blood within past 12 weeks or who has donated 200ml in past 4 weeks or plasma or platelets within past 2 weeks prior to this study. 13. Subjects who are pregnant or under lactation, or who expect to get pregnant during this study period. 14. Subject who has participated in other clinical trials within past one month or is currently undergoing any clinical trial. 15. Subjects who are judged ineligible by our physician.
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Clinical efficacy of Vortioxetine vs Escitalopram in depressive disorderCTRI/2022/07/043662Ahana Hospitals LLP
Completed
Unknown
Study to verify the effect of continuous consumption of the test food on improving skin conditioHealthy adultsJPRN-UMIN000049095M&I Science CORP.10
Completed
Not Applicable
A study on the effects of LPS-containing foods on immune functioHealthy personJPRN-UMIN000046154Innate Immune Network30
Active, not recruiting
Phase 1
12-Week study comparing Levodopa-Carbidopa Intestinal Gel / Levodopa Carbidopa Enteral Suspension to Optimized Medical Treatment on dyskinesia in subjects with advanced Parkinson's disease.Dyskinesia in advanced Parkinson's diseaseMedDRA version: 21.1Level: LLTClassification code 10013113Term: Disease Parkinson'sSystem Organ Class: 100000004852EUCTR2016-001403-23-ITABBVIE DEUTSCHLAND GMBH & CO. KG63
Active, not recruiting
Phase 1
12-Week study comparing Levodopa-Carbidopa Intestinal Gel / Levodopa Carbidopa Enteral Suspension to Optimized Medical Treatment on dyskinesia in subjects with advanced Parkinson's diseaseDyskinesia in advanced Parkinson's diseaseMedDRA version: 19.0Level: LLTClassification code 10013113Term: Disease Parkinson'sSystem Organ Class: 100000004852EUCTR2016-001403-23-ESAbbVie Deutschland GmbH & Co. KG63